Many animal experiments and epidemiological studies have been carried out since then to elucidate the mechanisms of radiation-induced carcinogenisis (BEIR III, 1980; UNSCEAR, 1977). It is now accepted that ionising radiation can induce cancer in most tissues, although there are great differences in organ susceptibility. The role of ionising radiation in human carcinogenisis is probably the best understood and quantified of all exogenous physical and chemical agents (BEIR V, 1989; UNSCEAR, 1988). Available information in based predominantly on studies of large populations receiving high dose exposures of short duration. Uncertainties remain, however, in particular about the magnitude of the risk associated with low dose exposures received over prolonged periods of time, such as those received by large populations in their occupational or residential environment (e.g. domestic radon).
The amount of repair of biological damage varies with the type of the radiation and there is little repair following densely ionising radiation. Repair also varies with the temporal distribution of an exposure. Accordingly, for equal total doses of gamma and X-rays more of the damage will be repaired for fractionated and protracted exposures than for acute exposures.
The concept of Quality Factor and, in particular, of Relative Biological Effectiveness (RBE) of a given radiation, was introduced as the ratio of the dose of a reference radiation and of the radiation of interest required to produce equal biological effects; 250 keV X-rays or 60Co X-rays are usually used as the reference. It is a function of many factors, including dose, temporal pattern of exposure, radiation type, biological system under consideration and specific end-point selected, e.g., cancer of a specific site or degree of cell damage. Energy deposition patterns clearly affect malignant transformation, sparsely ionising radiation being less efficient than more densely ionising radiation, although the exact mechanisms are currently unknown.
Estimates of RBEs for cancer have been derived based on results of epidemiological analyses and experiments on animals. The RBE for neutrons is often taken to be in the range of 5-10, depending on the site. However, various regulatory agencies are now considering the possibility of raising their estimates of quality factors for neutrons from 10 to 20; this would imply lowering the levels of permitted exposures, especially in reactor environments where the neutron component of the total dose may be important.
The most comprehensive experiments were performed on many thousands of mice in the US (see, e.g., those of Ullrich & Storer, 1979a,b,c). However, no simple conclusion can be drawn even from these very large experiments since the effects of dose and dose rate are complex and may vary from tissue to tissue. Further, tissue sensitivity and tumour expression may be influenced by hormonal status and by exposure to other carcinogens (chemical, physical or viral).
Sources of exposure | Exposure circumstances | Type of cancer reported [a] |
---|---|---|
Explosions of nuclear weapons | ||
blast | Atomic bomb survivors in Hiroshima and Nagasaki | Leukemia, breast, lung, thyroid, stomach, colon, bladder, multiple myeloma, oesophagus, ovary |
fall-out | Populations exposed through atmospheric testing, including the Marshall Islanders, veterans in the Pacific, general populations in Nevada and Utah | Thyroid, (leukemia) |
Diagnostic procedures | ||
X-rays | Children exposed in utero (1950--60s) | Leukemia |
thorotrast (thorium dioxide) | Cerebral and limb angiography, X-ray of biliary passages (prior to 1951) | Liver, (bone) |
fluoroscopic X-rays | Monitoring of lung infection in patients with tuberculosis | Breast cancer in women |
Therapeutic procedures | ||
X-ray | Post-partum mastitis | Breast |
X-ray | Ankylosing spondylitis | Leukemia, lung, stomach, oesophagus, (kidney, bladder, pancreas) |
Cobalt 60 X-ray and others | Treatment of cancer of the cervix | Leukemia, stomach, rectum, bladder, vagina, female genial, lung, buccal cavity, nasopharynx, oesophagus |
X-ray | Treatment of benign head and neck conditions (enlarged thymus, tinea capitis, etc) | Thyroid, skin, CNS |
Radium 224 | Ankylosing spondylitis, bone tuberculosis | Bone sarcoma |
Professional exposures | ||
X-ray | Early radiologists | Skin, leukemia |
Radon | Uranium, and hard-rock mines | Lung cancer |
X-ray, gamma rays, neutrons, some internal contamination | Nuclear industry | Multiple myeloma, (prostate, leukemia, lung) |
Radium isotopes | Radium dial painters | Bone, head sarcoma |